Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Oct;74(10):1333-1342.
doi: 10.1007/s00228-018-2507-4. Epub 2018 Jun 23.

Adequate, questionable, and inadequate drug prescribing for older adults at the end of life: a European expert consensus

Lucas Morin  1 , Marie-Laure Laroche  2   3 , Davide L Vetrano  4   5 , Johan Fastbom  4 , Kristina Johnell  4
Affiliations

Adequate, questionable, and inadequate drug prescribing for older adults at the end of life: a European expert consensus

Lucas Morin et al. Eur J Clin Pharmacol. 2018 Oct.

Abstract

Background: Clinical guidance is needed to initiate, continue, and discontinue drug treatments near the end of life.

Aim: To identify drugs and drug classes most often adequate, questionable, or inadequate for older people at the end of life.

Design: Delphi consensus survey.

Setting/participants: Forty European experts in geriatrics, clinical pharmacology, and palliative medicine from 10 different countries. Panelists were asked to characterize drug classes as "often adequate," "questionable," or "often inadequate" for use in older adults aged 75 years or older with an estimated life expectancy of ≤ 3 months. We distinguished the continuation of a drug class that was previously prescribed from the initiation of a new drug. Consensus was considered achieved for a given drug or drug class if the level of agreement was ≥ 75%.

Results: The expert panel reached consensus on a set of 14 drug classes deemed as "often adequate," 28 drug classes deemed "questionable," and 10 drug classes deemed "often inadequate" for continuation during the last 3 months of life. Regarding the initiation of new drug treatments, the panel reached consensus on a set of 10 drug classes deemed "often adequate," 23 drug classes deemed "questionable," and 23 drug classes deemed "often inadequate". Consensus remained unachieved for some very commonly prescribed drug treatments (e.g., proton-pump inhibitors, furosemide, haloperidol, olanzapine, zopiclone, and selective serotonin reuptake inhibitors).

Conclusion: In the absence of high-quality evidence from randomized clinical trials, these consensus-based criteria provide guidance to rationalize drug prescribing for older adults near the end of life.

Keywords: Drug prescribing; Inappropriate prescribing; Older adults; Palliative care; Quality of care.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

The regional ethical review Board in Stockholm, Sweden approved the study (decision no. 2015/1341-31/1).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Delphi process to reach consensus about the adequateness of drug prescribing in older people at the end of life
Fig. 2
Fig. 2
Flowchart used to determine consensus among panelists
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Todd A, Husband A, Andrew I, Pearson SA, Lindsey L, Holmes H. Inappropriate prescribing of preventative medication in patients with life-limiting illness: a systematic review. BMJ Support Palliat Care. 2017;7(2):113–121. doi: 10.1136/bmjspcare-2015-000941. - DOI - PubMed
    1. Molist Brunet N, Espaulella Panicot J, Sevilla-Sánchez D, Amblàs Novellas J, Codina Jané C, Altimiras Roset J, Gómez-Batiste X. A patient-centered prescription model assessing the appropriateness of chronic drug therapy in older patients at the end of life. Eur Geriatr Med. 2015;6(6):565–569. doi: 10.1016/j.eurger.2015.07.008. - DOI
    1. Maddison AR, Fisher J, Johnston G. Preventive medication use among persons with limited life expectancy. Prog Palliat Care. 2011;19(1):15–21. doi: 10.1179/174329111X576698. - DOI - PMC - PubMed
    1. Morin L, Vetrano DL, Rizzuto D, Calderón-Larrañaga A, Fastbom J, Johnell K. Choosing wisely? Measuring the burden of medications in older adults near the end of life: nationwide, longitudinal cohort study. Am J Med. 2017;130(8):927–936.e9. doi: 10.1016/j.amjmed.2017.02.028. - DOI - PubMed
    1. Currow DC, Stevenson JP, Abernethy AP, Plummer J, Shelby-James TM. Prescribing in palliative care as death approaches. J Am Geriatr Soc. 2007;55(4):590–595. doi: 10.1111/j.1532-5415.2007.01124.x. - DOI - PubMed

MeSH terms

Substances